-
Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States
Mar 10, 2025, 14:00 PM -
Hydroxyurea Use and Clinical Outcomes Among Adults with Severe Sickle Cell Disease: A retrospective Cohort Study using Electronic Health Record Data
Mar 10, 2025, 14:00 PM -
Real-World Utilization of Glucagon-Like Peptide-1 Receptor Agonists in Overweight and Obese US Adults
Mar 10, 2025, 14:00 PM -
Use of Diaries to Capture Patient-Reported Outcomes in FDA New Drug Approvals (2019-2023)
Mar 10, 2025, 14:00 PM -
Drivers of High ICERs in SMC Appraisals
Mar 10, 2025, 14:00 PM -
Hypophosphatasia (HPP) Patient & Caregiver Disease Burden, Quality of Life & Treatment Experience: A Mixed Methods Study Concept
Mar 10, 2025, 14:00 PM -
Landscape Review of Patient Engagement in the Health Technology Assessment (HTA) Process in Latin America
Mar 10, 2025, 14:00 PM -
Potential Added Clinical Value of Polygenic Risk Scores in Risk Assessment of Atherosclerotic Cardiovascular Disease
Mar 10, 2025, 14:00 PM -
Does a Digital Health Program Influence One’s Choice of Traditional Health Care? Changes in Health Care Use and Episodic Cost Among a Group of Chronic MSK Patients in a Digital Conservative Musculoskeletal Care Program
Mar 10, 2025, 14:00 PM -
Unveiling the Impact: Economic and Resource Utilization Analysis of Drug-Resistant Epilepsy Patients in the US
Mar 10, 2025, 14:00 PM -
A Retrospective Medical Expenditure Panel Survey Database Study Assessing Factors Associated with Health Status Among United States Adults with Asthma
Mar 10, 2025, 14:00 PM -
Explore the Prognostic Factors of Survival Outcomes in Newly Diagnosed Multiple Myeloma Who Are Not Transplant Eligible
Mar 10, 2025, 14:00 PM -
US Stakeholder Perspectives on Accumulators, Maximizers, and Alternative Funding Programs: Implications for Patient Affordability and Outcomes Research
Mar 10, 2025, 14:00 PM -
A Budget Impact Analysis of Introducing OPSYNVI for the Treatment of Adult Patients Diagnosed With Pulmonary Arterial Hypertension
Mar 10, 2025, 14:00 PM -
Demonstration of a Population-Level Biomarker Testing Economic Evaluation Tool for Oncology Interventions
Mar 10, 2025, 14:00 PM -
Developing a Budget Impact R Shiney Application to Assess the Financial Implications of Implementing Organized Cancer Screening Programs in Countries with Limited Resources: Breast Cancer as an Example
Mar 10, 2025, 14:00 PM -
Humanistic Burden in Metastatic Triple-Negative Breast Cancer (mTNBC): A Systematic Literature Review (SLR)
Mar 10, 2025, 14:00 PM -
Incorporating Social Drivers of Health Information Into Health Economics and Outcomes Research: Neighborhood-Level Proxies Versus Individual Level Data
Mar 10, 2025, 14:00 PM -
Comparing Predicted vs. Real-World Spending in the United States for Single-Administration Cell and Gene Therapies
Mar 10, 2025, 14:00 PM -
Pressures Behind the Rising Costs in Canadian Private Drug Plans: 2018-2023
Mar 10, 2025, 14:00 PM
